Armistice Capital Used COVID To Juice Vaxart Stock, Jury Told
Hedge fund Armistice Capital and two of its executives exploited the COVID-19 pandemic to issue press releases that falsely inflated their controlling share in pharmaceutical company Vaxart, then dumped the shares...To view the full article, register now.
Already a subscriber? Click here to view full article